ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...
Lithium has long been described as the "penicillin of psychiatry" and the "gold standard" in the treatment of bipolar disorder, yet its use in the United States has decreased steadily in the past 25 ...
ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...
Licensed as a psychiatric nurse practitioner more than 20 years ago, I thought I’d never need or want to prescribe lithium. Old school, I thought. A 1950s drug; we have much better now. It’s true, ...